Article

Study: Factors Associated With Use of Diabetes Self-Management Education, Support Programs in Newly Diagnosed Type 2 Diabetes Patients

There have not been many evaluations of the prevalence of, and factors associated with, use of DSME/S and support programs in newly diagnosed patients with type 2 diabetes (T2D) in Louisiana, according to the study authors.

The use of diabetes self-management education and support (DSME/S) programs is low in the state of Louisiana and there are marked differences in use of the service by insurance type, smoking status, and diabetes risk control, according to a poster session at the American Diabetes Association’s 80th virtual Scientific Sessions.

There have not been many evaluations of the prevalence of, and factors associated with, use of DSME/S and support programs in newly diagnosed patients with type 2 diabetes (T2D) in Louisiana, according to the study authors.

To further analyze the programs, the researchers used electronic health records from 3 hospital systems in Louisiana. Eligible patients were 35 to 94 years of age with T2D based on ICD-codes, an antidiabetic drug prescription, an HbA1c ≥6.5%, an FPG ≥126, a 2-hour OGT ≥200, or random plasma glucose ≥200 mg/dL. New T2D was defined as entry of T2D diagnosis in the condition list occurring less than 1 year after the first recorded office visit.

The results found that the prevalence of DSME/S use in T2D patients was 5.6%, whereas the prevalence was 6.2% in newly diagnosed T2D patients. Compared with the gender-, age-, and race-matched non-DSME/S group, the DSME/S group had worse clinical profiles, such as higher mean A1c and triglycerides and a higher obesity rate.

Adjusted models showed self-pay patients were 70% less likely to use DSME/S than Medicare beneficiaries, according to the study authors. Further, current smokers were 2.6 times more likely to use DSME/S than never smokers, whereas former smokers were 40% less likely than never smokers.

Patients with hypolipidemic or antihypertensive drugs were 50% or 60% more likely to use DSME/S than those without the medications. According to the study authors, patients with A1c >6.5% were 3.9 times more likely to use DSME/S than those with normal A1c. Obese patients were 60% more likely to use DSME/S, whereas hypertensive patients were 60% more likely to use DSME/S.

REFERENCE

Yoshida Y, Shi L, Hong D, et al. Factors Associated with Use of Diabetes Self-Management Education and Support Programs in Newly Diagnosed Type 2 Diabetes Patients in Louisiana. American Diabetes Association: 80th Scientific Sessions: A Virtual Experience, June 12-16, 2020. https://plan.core-apps.com/tristar_ada20/abstract/28c43556-c34b-4dca-8865-f33499ecc1d3.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Magnified bone marrow biopsy showing plasma cells with irregular nuclei and multiple myeloma tumor cells infiltrating normal hematopoietic tissue
Image credit: Dr_Microbe | stock.adobe.com